Soluble gp350/220 and deletion mutant glycoproteins block Epstein-Barr virus adsorption to lymphocytes

Keyphrases

• Glycoprotein 100%
• Epstein-Barr Virus 100%
• Lymphocytes 100%
• Deletion mutant 100%
• Virus Adsorption 100%
• Gp350 100%
• Amino 77%
• Amino Acids 55%
• B Lymphocytes 44%
• Surface Sites 11%
• High Affinity 11%
• Scatchard Analysis 11%
• Epitope 11%
• Virus Infection 11%
• Receptor Blockade 11%
• Ligand-receptor Binding 11%
• Specific Monoclonal Antibodies 11%
• Neutralizing Monoclonal Antibody 11%
• Lymphocyte Receptors 11%
• Plasma Membrane Proteins 11%
• Envelope Glycoprotein 11%

Immunology and Microbiology

• Glycoprotein 100%
• Virus Attachment 100%
• Epstein Barr Virus 100%
• Lymphocyte 100%
• Deletion Mutant 100%
• Amino Terminal Sequence 87%
• B Cell 37%
• Monoclonal Antibody 25%
• Surface Property 12%
• Epitope 12%
• Cell Membrane 12%
• Receptor Blocking 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Epstein-Barr Virus 100%
• Adsorption 100%
• Glycoprotein 100%
• Amino Acid 62%
• Infection 25%
• Monoclonal Antibody 25%
• Receptor 12%
• Membrane Protein 12%
• Epitope 12%
• B Lymphocyte Receptor 12%